We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Highlights Ethnic Diversity of Lupus-Linked Genes

By LabMedica International staff writers
Posted on 03 Aug 2017
A large genotyping study has identified multiple regions of the genome linked to the autoimmune disease systemic lupus erythematosus (SLE) in individuals of European, African, and Hispanic Amerindian ancestry.

SLE is an autoimmune disease with marked gender and ethnic disparities. More...
For example SLE strikes women nine times more frequently than men and its onset is most common during the childbearing years. Furthermore, African-American and Hispanic women are two to three times more likely to develop lupus and tend to have more severe cases than Caucasian women.

A recent study conducted by investigators at Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) and colleagues in Oklahoma, the United Kingdom, and at the biotechnology company Genentech Inc. (San Francisco, CA, USA) analyzed genetic data from 27,574 individuals of European, African American, and Hispanic ancestry using Immunochip genotyping technology that had been designed specifically for autoimmune diseases.

The investigators reported that they had identified 58 regions of the genome linked to SLE in Caucasians, nine in African Americans, and 16 in Hispanics. These regions appeared to be independent of association with HLA (Human Leukocyte Antigen), and nearly 50% of these regions had multiple genetic variants that predisposed to SLE.

"This study is the largest multi-ethnic lupus genetics study to date and allowed us to identify many new genetic markers, some of which are specific to individual ethnic groups and others that are shared across ethnicities," said first author Dr. Carl Langefeld, professor of biostatistical sciences at Wake Forest Baptist Medical Center. "With this information, we can begin to better understand the differences in the rates and severity of disease across ethnic groups. In addition, we observed that many of the genetic markers associated with lupus are shared across numerous autoimmune diseases, and those that are not shared may allow us to understand why a person develops lupus instead of another autoimmune disease. These results will help us identify the biological pathways that pharmaceutical companies may target, and ultimately, develop personalized medicine for the treatment of lupus."

The study was published in the July 17, 2017, online edition of the journal Nature Communications.

Related Links:
Wake Forest Baptist Medical Center
Genentech



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
Manual Pipetting Aid
Pipette Controllers macro
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.